학술논문
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).
Document Type
Article
Author
Badar, Talha; Nanaa, Ahmad; Atallah, Ehab; Shallis, Rory M.; Guilherme, Sacchi de Camargo Correia; Goldberg, Aaron D.; Saliba, Antoine N.; Patel, Anand; Bewersdorf, Jan P.; DuVall, Adam S.; Bradshaw, Danielle; Abaza, Yasmin; Murthy, Guru Subramanian Guru; Palmisiano, Neil; Zeidan, Amer M.; Kota, Vamsi; Litzow, Mark R.
Source
Blood Cancer Journal; 2/20/2024, Vol. 14 Issue 1, p1-4, 4p
Subject
Language
ISSN
20445385
Abstract
Copyright of Blood Cancer Journal is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)